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Enolase-phosphatase 1 (ENOPH1), a newly discovered enzyme of the methionine
salvage pathway, is emerging as an important molecule regulating stress responses. In
this study, we investigated the role of ENOPH1 in blood brain barrier (BBB) injury under
ischemic conditions. Focal cerebral ischemia induced ENOPH1 mRNA and protein
expression in ischemic hemispheric microvessels in rats. Exposure of cultured brain
microvascular endothelial cells (bEND3 cells) to oxygen-glucose deprivation (OGD) also
induced ENOPH1 upregulation, which was accompanied by increased cell death and
apoptosis reflected by increased 3-(4, 5-Dimethylthiazol-2-yl)-2, 5- diphenyltetrazolium
bromide formation, lactate dehydrogenase release and TUNEL staining. Knockdown
of ENOPH1 expression with siRNA or overexpressing ENOPH1 with CRISPR-
activated plasmids attenuated or potentiated OGD-induced endothelial cell death,
respectively. Moreover, ENOPH1 knockdown or overexpression resulted in a significant
reduction or augmentation of reactive oxygen species (ROS) generation, apoptosis-
associated proteins (caspase-3, PARP, Bcl-2 and Bax) and Endoplasmic reticulum
(ER) stress proteins (Ire-1, Calnexin, GRP78 and PERK) in OGD-treated endothelial
cells. OGD upregulated the expression of ENOPH1’s downstream protein aci-reductone
dioxygenase 1 (ADI1) and enhanced its interaction with ENOPH1. Interestingly,
knockdown of ENOPH1 had no effect on OGD-induced ADI1 upregulation, while it
potentiated OGD-induced ADI1 translocation from the nucleus to the cytoplasm. Lastly,
knockdown of ENOPH1 significantly reduced OGD-induced endothelial monolayer
permeability increase. In conclusion, our data demonstrate that ENOPH1 activation may
Abbreviations: BSA, Bovine albumin; DAPI, 4′,6-diamidino-2-phenylindole; DCF-DA, 2,7-dichlorodihydrofluorescein
diacetate; EDTA, Eathylene diamine tetraacetic acid; FACS, Fluorescence-activated cell sorting; FITC, fluorescein
isothiocyanate; PBS, Phosphate Buffered Saline; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP-biotin
nick end labeling.
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contribute to OGD-induced endothelial cell death and BBB disruption through promoting
ROS generation and the activation of apoptosis associated proteins, thus representing
a new therapeutic target for ischemic stroke.
Keywords: ENOPH1, oxygen-glucose deprivation, cerebral ischemia, blood brain barrier, apoptosis
INTRODUCTION
Ischemic stroke is a leading cause of disability and mortality
in humans. Cerebral ischemia initiates a cascade of cytotoxic
molecules responsible for the death of neural cells as well as
the damage of the blood brain barrier (BBB) at the injury
site. The polyamines, such as putrescine, spermindine and
spermine, are elevated in the ischemic parenchyma and
contribute to ischemic brain damage via enhancing N-methy-
D-aspartate receptor-mediated excitotoxicity, generating
toxic aldehydes and reactive oxygen species (ROS), and
disrupting oxidative metabolism and mitochondrial function
(Takano et al., 2005; Kim et al., 2009). The administration
of polyamine antagonists prevents the development of
ischemic brain damage (Takano et al., 2005; Li et al.,
2007).
Enolase-phosphatase 1 (ENOPH1) is a newly identified
enzyme of themethionine salvage pathway, a ubiquitous pathway
for the reconstitution of methionine, which is required for the
synthesis of polyamine (Sauter et al., 2013). A recent study
shows that ENOPH1 is widely expressed in the brain and stress
exposure increases ENOPH1 protein levels in brain tissue of
C57BL/6Jmice (Barth et al., 2014). Since ENOPH1 participates in
the synthesis of polyamine indirectly via S-adenosyl methionine
(SAM; Takano et al., 2005; Li et al., 2007; Kim et al., 2009;
Duan et al., 2011), it is logical to speculate a role of ENOPH1
in ischemic brain injury.
BBB disruption is a common event in ischemic stroke,
which leads to vasogenic brain edema and hemorrhagic
transformation (Sandoval and Witt, 2008; Hawkins et al.,
2014). Brain capillary endothelial cells form the backbone of
the BBB structure, their death or apoptosis can result in
catastrophic failure of BBB’s integrity (ElAli et al., 2011; Wang
et al., 2011). We have obtained preliminary data showing
that cerebral ischemia induces ENOPH1 mRNA expression
in ischemic cerebral microvessels in a rat model of middle
cerebral artery occlusion (MCAO; Figure 1). However, the
exact role of ENOPH1 in BBB damage remains to be
determined.
In this study, we applied in vitro cultured brain microvascular
endothelial monolayer and oxygen-glucose deprivation (OGD)
to mimic the BBB and ischemia, respectively, and explored
the role of ENOPH1 in ischemic BBB damage. Our data
showed that OGD induced a significant increase in the
protein levels of ENOPH1 and its downstream molecule aci-
reductone dioxygenase 1 (ADI1) in cultured brain endothelial
cells, which led to increased ROS generation, endothelial
cell apoptosis and increased permeability of endothelial
monolayer.
MATERIALS AND METHODS
Rat Model of MCAO
The Laboratory Animal Care and Use Committee of Shenzhen
University approved all experimental protocols. Male Sprague
Dawley rats (Southern Medical University, Guangzhou,
Guangdong, China) weighing 290–320 g were anesthetized
with isoflurane (4% for induction, 1.75% for maintenance) in
N2O:O2 (70%:30%) during surgical procedures and the body
temperature was maintained at 37.5± 0.5◦C using a heating pad.
The rats were subjected to 3 h MCAO using the intraluminal
filament technique as previously described (Liu et al., 2009).
Briefly, a 4–0 silicone-coated monofilament nylon suture was
inserted into the internal carotid artery and advanced along
the internal carotid artery to approximately 17–18 mm from
the bifurcation, thereby blocking the ostium of the MCA. At
the end of 3 h MCAO, rats were sacrificed and the brains were
removed for microvessel isolation as described below. For a total
number of 12 rats included in this study, successful MCAO was
confirmed by 2,3,5-triphenyltetrazolium chloride (TTC) staining
of the 1 mm-thick brain coronal section 6 mm away from the tip
of the front lobe as we described previously (Liu et al., 2008).
Isolation of Cerebral Microvessels
Isolation of cerebral microvessels was carried out as we
described previously (Liu et al., 2009). Briefly, the hemispheric
brain tissue was dissected and homogenized in ice cold
Phosphate Buffered Saline (PBS). The homogenate was
filtered through a 41 µm nylon mesh (Spectrum), and the
nylon mesh was washed three times with PBS. Microvessels
retained on the mesh were then washed off and pelleted by
centrifugation at 4000 g for 10 min at 4◦C. The pellets were
resuspended in 15% dextran T-500 and then added onto
20% dextran T-500, followed by centrifugation at 25,000 g
for 10 min at 4◦C. The pellets were collected at the cerebral
microvessels and used for measuring ENOPH1 mRNA and
protein expression by real time RT-PCR and western blot,
respectively.
Cell Cultures
Mouse brain microvascular endothelial cells (bEND3 cells;
American Type Culture Collection, VA, USA) were grown as
a monolayer in Dulbecco’s modified Eagle’s medium (DMEM)
with 10% fetal bovine serum (FBS), 100 U/ml penicillin and
100 µg/ml streptomycin at 37◦C in a humidified incubator
gassed with 5% CO2 and 95% room air. The cells were
grown to confluence on type I collagen-coated 60 mm dishes
before exposure to OGD. For the assays, cell cultures were
initiated at a density of 5 × 105 cells/ml to have cells
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FIGURE 1 | Middle cerebral artery occlusion (MCAO) induces
Enolase-phosphatase 1 (ENOPH1) upregulation in ischemic cerebral
microvessels. Rats were subjected to 3 h MCAO before isolating
hemispheric cerebral microvessels. The mRNA and protein levels of ENOPH1
in cerebral microvessels from nonischemic (Non-I) and ischemic (I)
hemispheric tissue were analyzed by real-time RT-PCR and western blot.
(A) Representative photographs of triphenyltetrazolium chloride (TTC) stained
1 mm-thick brain sections showing tissue infarction (pale white region) in the
ischemic hemispheres (right). (B) Real-time RT-PCR analysis showed that
ENOPH1 mRNA expression was significantly increased in ischemic
hemispheric microvessels. ∗P < 0.05 vs. Non-I; n = 6. (C) Western blot
analysis revealed increased levels of ENOPH1 protein in ischemic hemispheric
microvessels. Upper panel: representative immunoblots of ENOPH1 and the
loading control β-actin; bottom panel: quantitative data of protein band
intensity after normalization to β-actin. ∗P < 0.05 vs. Non-I; n = 6.
in the exponential growth phase. The number of cells was
determined with a hemocytometer (Adam MC, Digital bio,
Korea).
OGD Treatment
To mimic ischemic condition in vitro, bEND3 cells were
exposed to OGD as described previously (Liu et al., 2012).
In brief, confluent bEND3 cells were subjected to OGD by
replacing the normal growth medium with glucose free medium
(DMEM without glucose) pre-equilibrated with 95% N2 and
5% CO2. The cells were then incubated in a humidified
airtight chamber (Biospherix Ltd., Lacona, NY, USA) for
1, 3 or 6 h. Control cultures were incubated with normal
DMEM medium without FBS at 37◦C in 5% CO2/95% air.
The cells were collected for further analyses immediately after
OGD treatment.
Lactate Dehydrogenase Release Assay
After OGD treatment, cell viability was measured using
a CytoTox 96rNon-Radioactive Cytotoxicity Assay Kit
(Promega) according to manufacturer’s instruction. Briefly,
50 µl of each sample medium (e.g., pure culture medium
for measuring background LDH release, culture media
collected from control or OGD-treated cells for measuring
experimental LDH release and lysis buffer-treated cells
for measuring maximum LDH release) was collected to
assay LDH release. The samples were incubated with the
reduced form of nicotinamide-adenine dinucleotide and
pyruvate for 30 min at room temperature and the reaction
was terminated by adding Stop Solution. LDH release was
assessed by measuring the absorbance of supernatants at
490 nm. The cell death rate was calculated as follows: cell
death rate = (experimental LDH release − background
LDH release)/(maximum LDH release-background LDH
release) × 100%. The results were presented as fold increase of
the control cells.
Knockdown of ENOPH1 with siRNA
bEND3 cells at 60–70% confluence on 6- and 24-well plates
were transfected with 100 nM ENOPH1 siRNA (si-ENOPH1,
sc-144654, Santa Cruz, CA, USA) or scrambled control siRNA
(si-control, sc-37007, Santa Cruz, CA, USA) using siRNA
transfection reagent (sc-29528) according to the manufacturer’s
instruction. Forty-eight hours after transfection, cells were
subjected to OGD treatment. Specific silencing was confirmed by
western blot.
ENOPH1 CRISPR Activation Plasmid
Transfection
bEND3 cells grown to 60–80% confluence were transfected with
the ENOPH1 overexpression plasmid (ENOPH1 CRISPR
activation plasmid, Santa Cruz, CA, USA) or control
plasmid (control CRISPR activation plasmid, Santa Cruz,
CA, USA) using UltraCruzr Transfection Reagent (Santa
Cruz Biotech) according to the manufacturer’s instruction.
In brief, for each transfection, a 300 µl mixture of 1 µg
of plasmid DNA with 10 µl of UltraCruzr transfection
reagent in plasmid transfection medium was added to
each well. Forty-eight hours after transfection, cells were
subjected to OGD treatment and subjected to various
assays.
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In vitro BBB Model of Endothelial
Monolayer
An endothelial monolayer grown on a cell culture insert is widely
used for in vitro BBB models. Nunc cell culture inserts (for
24-well plates) with 0.02 µm Anapore membranes (Nunc Inc.,
Naperville, IL, USA) were coated by incubation with 70 µg/ml
type I collagen (Sigma, St. Louis, CA, USA) in 20 mM acetic
acid for 1 h at 25◦C. The inserts were then washed with serum
free medium to remove excess protein before adding complete
medium to equilibrate the membrane for 3 h at 37◦C in a cell
culture incubator. Then, the endothelial cells were trypsinized
from the tissue culture flasks, washed three times with complete
medium, and seeded on the inserts at 20,000 cells/cm2. The cells
seeded on inserts were allowed to grow for 3–4 days at 37◦C in
5% CO2/95% air to achieve full confluence, which was confirmed
under a phase contrast microscopy.
Endothelial Cell Monolayer Permeability
Assay
Endothelial monolayer permeability after OGD was measured
as we described previously (Liu et al., 2012). Briefly, bEND3
cells were placed on the upper side of the insert and
allowed to grow to confluence. Then, 3.5 µM fluorescein
isothiocyanate (FITC)-dextran was added to the endothelial
monolayer (luminal compartment) before expose to OGD
for 6 h. After OGD treatment, the contents of FITC-
dextran in both luminal and abluminal compartments were
determined and endothelial monolayer permeability was assessed
by calculating the apparent permeability coefficient (Papp) as
previously described (Grabovac and Bernkop-Schnürch, 2006):
Papp [cm/s] = dQ/(dt∗A∗Co), where dQ was the amount of
FITC-dextran getting into the abluminal compartment, dt was
duration of OGD treatment, dQ/dt was the rate of transfer (ng/s),
A was surface area (cm2), and Co was the initial concentration
in the luminal chamber (ng/cm3). To test whether ENOPH1
were implicated in OGD-induced endothelial barrier disruption,
cells were pretreated with ENOPH1 siRNA for 48 h before OGD
treatment.
Detection of Intracellular Reactive Oxygen Species
(ROS) Generation
Intracellular ROS generation was assessed by quantifying
fluorescence intensity under a fluorescent microscope
or by flow cytometry analysis after staining with
2,7-dichlorodihydrofluorescein diacetate (DCF-DA). The
bEND3 cells were pre-incubated in a 24- or 6-well culture plate
for 24 h. Subsequently, the cells were transfected with control
or ENOPH1 siRNA for 48 h at 37◦C. After transfection, the
bEND3 cells were treated with OGD for 6 h before incubating
with 10 µM DCF-DA (Sigma, St. Louis, MO, USA) for 30 min
at 37◦C. The cells were then photographed under a fluorescent
microscope (Leica, Germany) or resuspended and incubated
for another 10 min with propidium iodide (10 µg/ml) before
analyzing ROS with a Fluorescence-activated cell sorting (FACS)
calibur flow cytometer (Becton Dickinson, excitation: 488 nm).
ROS fluorescence was quantified and expressed as fold increase
of the control cells.
Western Blot Assay
After indicated treatment, the cells grown on 6 or 10
cm culture dish were harvested and lysed in a cold lysis
buffer [50 mM Tris (pH 7.4), 150 mM NaCl, 2 mM
Ethylene diamine tetraacetic acid (EDTA), 10% glycerol,
1% TritonX-100, 1 mM phenylmethylsulfonyl fluoride
(PMSF) and 2% protease inhibitor mixture (Sigma, St.
Louis, MO, USA)]. The cell lysates were centrifuged for
15 min at 12,000 g at 4◦C and protein concentrations were
determined using PierceTM BCA Protein Assay Kit (Thermo
Fisher Scientific Inc, Waltham, MA, USA). The cell lysates
(30 µg protein/lane) were subjected to electrophoresis on
10–12% sodium dodecyl sulfate (SDS)-polyacrylamide gels
and transferred to polyvinylidene difluoride membrane.
The membranes were blocked in Trisbuffered saline with
0.05% Tween-20 (TBS-T) containing 5% nonfat milk and
blotted overnight with primary antibodies (dilution: 1:1000).
The membranes were washed and incubated for 1 h with
horseradish peroxidase (HRP)-conjugated secondary antibodies
(dilution: 1:1000, Jackson ImmunoResearch, West Grove, PA,
USA). The membranes were washed and developed using
a chemiluminescence kit (Fisher Scientific). The primary
antibodies were cleaved-caspase-3, caspase-3, cleaved-PARP,
Bcl-2, Bax, PARP, ADI1, PERK, Calnexin, Ire-1α, ENOPH1
and β-actin. ENOPH1 antibody was a product of Proteintech
(Cat. Log: 11763-1-AP), and the rest primary antibodies
were purchased from Santa Cruz Biotech. Relative protein
levels were normalized to β-actin. For subcellular fraction
samples, we noticed that the actin levels were comparable for
each sample among different fractions, so we only used one
normalizing loading control (CF actin) for all three subcellular
fractions.
Coimmunoprecipitation of ENOPH1 with ADI1
Coimmunoprecipitation was performed as described previously
(Wen et al., 2010). Briefly, bEND3 cells were subjected to OGD
treatment for 6 h and then lysed on ice in 1 ml RIPA buffer. After
pre-clearing with normal IgG, cell lysates (0.5 mg of protein)
were incubated overnight at 4◦C with 2 µg of anti-ENOPH1
(Proteintech, Chicago, IL, USA), followed by precipitation with
20 µl of protein A/G Plus-Agarose (Pierce Biotechnology,
Rockford, IL, USA) for 1 h at 4◦C. The precipitated complexes
were separated on SDS-PAGE gels and immunoblotted with
anti-ADI1 (Santa Cruz Biotech., Dallas, TX, USA) to detect the
presence of this protein in the complex, as described above.
Immunocytochemistry
bEND3 cells grown on type I collagen-coated coverslips
were exposed to OGD for 6 h before fixation with 4%
paraformaldehyde and permeabilization with 0.1% Triton
X-100. After blocking non-specific binding with a blocking
solution (3% BSA, 0.1% Tween 20 and 5% goat serum in PBS),
the cells were incubated overnight at 4◦C with anti-ENOPH1
(Proteintech, 1:200) primary antibodies, then followed by
FITC anti-mouse secondary antibodies (Invitrogen, 1:200)
for 1 h at room temperature. Coverslips were mounted
on glass slides using anti-fade sealed solution (Beyotime
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Biotechnology, Jiangsu, China) and immunostaining was
visualized under a DMI6000B fluorescence microscope
(Leica, Germany). The average fluorescence intensity of
single nuclei (Iav) and the area (A) that they occupied
in the image were determined and the integrated optical
density (IOD), which is proportional to the amount of
incorporated ENOPH1 antibody, was calculated by the formula:
IOD= Iav ∗A.
Real-Time RT-PCR
Total RNA was isolated from endothelial cells using Trizol
reagent (Invitrogen, Carlsbad, CA, USA). RNA samples (2 µg)
were reverse-transcribed to generate first-strand cDNA. After
reverse transcription using TaqManr Reverse Transcription
Kits (Applied Biosystems), 0.5 µl reverse-transcribed products
were amplified with the Vii7 real-time PCR System (Applied
Biosystems) in a 10µl final reaction volume using SYBRr Green
PCR Master Mix (Applied Biosystems) under the following
conditions: 30 s at 95◦C, followed by a total of 40 cycles of
two temperature cycles (15 s at 95◦C and 1 min at 60◦C).
Primer sequences were as follows: rat ENOPH1 forward: 5′-
ACCACAACCCCGATTGCTTT-3′ and reverse: 5′-TTCTT
CAGCCTGCTTCCTCA-3′; mouse ENOPH1 forward: 5′-ACC
ACAACCCCGATTGCTTT-3′ and reverse: 5′-TTCCTCGGCCT
GTTTCCTCA-3′; mouse ADI1 forward: 5′-CCGAATGGAAAG
TTGCTC-3′ and reverse: 5′-TAAGTCTTGACAGTTAGGGA-
3′; GAPDH served as endogenous control, and the primers were
forward: 5′-CAATGTGTCCGTCGTGGAT CT-3′; reverse:5′-
GTCCTCAGTGTAGCCCAAGATG-3′. The Ct value was
calculated by the comparative ∆∆Ct method using the SDS
Enterprise Database software (Applied Biosystems).
TUNEL Assay
Apoptosis was analyzed by TUNEL assay using Click-iTr Plus
TUNEL Assay (Life Technologies, Inc., Carlsbad, CA, USA)
according to manufacturer’s instruction. In brief, at the end
of the indicated treatments, bEND3 cells grown on coverslips
were incubated with TdT reaction mixture for 2 h at 37◦C,
followed by 30 min incubation with the Alexa Fluorr 594
dye (red fluorescence). Then, the cells were counterstained
with DAPI (Sigma-Aldrich) for 20 min and observed under a
fluorescencemicroscope (magnification,×200; Leica, Germany).
The TUNEL-positive nuclei of six non-overlapping fields per
coverslip were counted by a researcher blinded to treatment,
and these counts were converted to percentages by comparing
the TUNEL-positive counts to the total number of cell nuclei
as determined by DAPI counterstaining, that is TUNEL-positive
ratio= (number of red nuclei/number of blue nuclei)× 100%.
Statistical Analysis
All data were expressed as means ± SEM. Differences between
groups were evaluated by either an unpaired Student’s t-test
or one-way analysis of variance (ANOVA) followed by Tukey’s
post hoc test. A value of P < 0.05 was considered statistically
significant.
RESULTS
ENOPH1 is Upregulated in Ischemic
Cerebral Microvessels
ENOPH1 is found to be widely expressed in the brain and is
implicated in stress response (Barth et al., 2014). To determine
whether ENOPH1 plays a role in ischemic BBB injury, we first
examined the change of ENOPH1 expression in the BBB, i.e.,
the cerebral microvessels or capillaries, isolated from the rats
that were subjected to 3 h MCAO without reperfusion. TTC
staining of the 1 mm-thick brain sections collected from the
six rats included in this study showed visible tissue infarction
(no TTC staining, white color) in the MCA supplied area of the
right hemisphere after 3 hMCAO (Figure 1A). ENOPH1mRNA
expression was analyzed in isolated hemispheric microvessels
by real time RT-PCR and found that 3 h MCAO induced a
significant increase (∼1-fold) of ENOPH1 mRNA expression
in ischemic hemispheric microvessels compared to nonischemic
microvessels tissue (Figure 1B). Consistent with its mRNA
change, ENOPH1 protein levels were also significantly increased
in ischemic cerebral microvessels (Figure 1C). These results
demonstrate that ENOPH1 is upregulated in the ischemic brain
microvessels. To further demonstrate the role of ENOPH1 in
ischemic BBB injury and the underlying mechanisms involved,
we chose the widely used in vitro model of BBB (i.e., brain
microvascular endothelial cell monolayer) and the in vitromodel
of ischemia (i.e., OGD) for the rest of this study.
OGD Induces ENOPH1 Expression in Brain
Endothelial Cells
As mentioned earlier, ENOPH1 is a newly identified protein
and little is known about its biological function. So far,
there are no specific pharmacological inhibitors or genetics-
manipulated animals available, therefore we chose the widely
used in vitromodel of BBB (i.e., cultured endothelial monolayer)
and the in vitro model of ischemia (i.e., OGD) to investigate
whether ENOPH1 plays a role in ischemic BBB injury. Brain
endothelial cells bEND3 were exposed to OGD for 1, 3, or
6 h before analyzing ENOPH1 mRNA and protein levels.
Real time RT-PCR analysis showed that ENOPH1 mRNA
expression was increased in bEND3 cells after exposing to
OGD for 1 h and was further increased at 6 h OGD, while
no significant difference was seen between 1 h and 3 h OGD
(Figure 2A). Western blot analysis showed that ENOPH1
protein levels were significantly increased in bEND3 cells after
exposing to OGD for 3 h, but not for 1 h (Figure 2B).
Different from the mRNA result, 6 h OGD did not further
increase ENOPH1 protein levels in bEND3 cells compared
to 3 h OGD (Figure 2B). To further verify the immunoblot
findings and to reveal ENOPH1’s intracellular localization,
we performed immunocytochemical staining after exposing
bEND3 cells to OGD for 6 h. As shown in Figure 2C,
immunostaining revealed that ENOPH1 protein was located in
the cytosol of bEND3 cells and OGD treatment significantly
increased ENOPH1’s fluorescence intensity (∼1.5-fold increase)
compared to control (normoxic) cells. These data demonstrate
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FIGURE 2 | Oxygen-glucose deprivation (OGD) induces upregulation of
ENOPH1 in brain microvascular endothelial cells (bEND3 cells). bEND3
cells were subjected to OGD treatment or normoxia (Control, Con) for 1, 3, or
6 h before analyzing ENOPH1 mRNA and protein expression using real-time
RT-PCR, western blot and immunostaining. (A) Real time RT-PCR analysis
showed that ENOPH1 mRNA expression was significantly increased in bEND3
cells at 1 h after OGD treatment and was further increased when OGD was
prolonged to 6 h. ∗P < 0.05 vs. Con; n = 4. (B) Western blot analysis
(Continued)
FIGURE 2 | continued
showed that ENOPH1 protein levels were increased in 3 h OGD and 6 h OGD
treated cells, but not in 1 h OGD treated cells. Upper panel: representative
immunoblots of ENOPH1 and the loading control β-actin; bottom panel:
quantitative data of protein band intensity after normalization to β-actin.,
∗P < 0.05 vs. Con; n = 4. (C) bEND3 cells were exposed to OGD for 6 h
before immunostaining with ENOPH1 (green), and nuclei were counterstained
with DAPI (blue). Upper panel: representative immunocytochemical
micrographs showed that ENOPH1 was located in the cytosol and OGD
significantly enhanced ENOPH1’s fluorescence intensity (bar = 20 µm);
bottom panel: the intensities of ENOPH1 immunofluorescence were
quantitated and expressed as IOD parameter. ∗P < 0.05 vs. Con; n = 4. IOD,
integrated optical density.
that OGD significantly induces ENOPH1 upregulation in brain
endothelial cells.
Knockdown of ENOPH1 Inhibits
OGD-Induced Endothelial Cell Apoptosis
To determine whether ENOPH1 contributes to ischemia-
induced BBB injury, we applied siRNA approach to knock down
ENOPH1 expression in bEND3 cells and assessed its effect
on 6 h OGD-induced endothelial apoptosis. The efficacy of
ENOPH1 siRNA in knocking down ENOPH1 expression was
shown in Figure 3A, in which a ∼90% reduction in ENOPH1
protein level was seen on immunoblots at 48 h after ENOPH1
siRNA transfection. The effect of ENOPH1 siRNA on OGD-
induced endothelial cell death was assessed by measuring LDH
release (indicating late apoptosis and necrosis) and TUNEL
staining (indicating apoptosis). As shown in Figure 3B, 6 h
OGD significantly induced endothelial cell death, with a death
rate of 46.74% ± 2.15 vs. 16.19% ± 1.24 of the control cells.
Knockdown of ENOPH1 with siRNA had no effect on LDH
release from control bEND3 cells, while it significantly reduced
OGD-induced cell death. TUNEL staining showed a similar
protective effect of ENOPH1 siRNA on OGD-induced apoptosis,
with 19.98% ± 2.03 TUNEL-positive cells for OGD alone vs.
7.14%± 0.95 for OGD plus ENOPH1 siRNA (Figure 3C).
To further verify a role of ENOPH1 in OGD-induced
bEND3 cell apoptosis, we assessed the effect of ENOPH1 siRNA
on several key apoptosis-associated signal proteins including
caspase-3, PARP and Bax/Bcl-2. As shown in Figures 4A,B, 6 h
OGD induced increased levels of cleaved caspase-3 (caspase-
3 activation), cleaved PARP-1 and higher ratio of Bax/Bcl-2
in bEND3 cells, and transfection with ENOPH1 siRNA, but
not control siRNA, abolished these changes. As expected,
ENOPH1 siRNA alone did not affect these apoptosis-associated
signal proteins under control conditions (Figures 4A,B). Taken
together, these results clearly indicate that ENOPH1 is involved
in OGD-induced apoptosis in brain endothelial cells.
Knockdown of ENOPH1 Abolishes
OGD-Induced Oxidative Stress in bEND3
Cells
We next asked how ENOPH1 promoted microvascular
endothelial cell injury after ischemic stimulation. Endoplasmic
reticulum (ER) stress and oxidative stress are well-known
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FIGURE 3 | Knockdown of ENOPH1 attenuates OGD-induced apoptosis in bEND3 cells. (A) ENOPH1 siRNA effectively knocked down ENOPH1 protein
expression in bEND3 cells. Western blot analysis showed that incubation bEND3 cells with ENOPH1 siRNA (siENO) for 48 h significantly (∼90%) reduced ENOPH1
protein levels. Upper panel: representative immunoblots of ENOPH1 and the loading control β-actin; bottom panel: quantitative data of protein band intensity after
normalization to β-actin. ∗P < 0.05 vs. Control siRNA (siCon); n = 4. (B) Knockdown of ENOPH1 significantly reduced 6 h OGD-induced cell death assessed by LDH
release. ∗P < 0.05 vs. siCon; #P < 0.05 vs. siCon + OGD; n = 4. (C) TUNEL assay showed that 6 h OGD significantly increased the number of TUNEL-positive
apoptotic endothelial nuclei (red fluorescence) and knockdown of ENOPH1 significantly decreased this increase. Left panel: representative micrographs of double
staining of TUNEL and DAPI (blue, counter staining), bar = 50 µm; right panel: quantitative data of TUNEL-positive cells. ∗P < 0.05 vs. siCon + OGD; Experiments
were repeated four times (n = 4).
mediators for BBB damage in ischemic stroke (Kaur and
Ling, 2008; Yang et al., 2014). We speculated that ENOPH1
might contribute to ischemic bEND3 cell death/apoptosis
through potentiating ER stress and oxidative stress under
OGD conditions. To test this possibility, bEND3 cells were
transfected with ENOPH1 siRNA before exposing the cells
to OGD for 6 h. ER chaperone proteins (calnexin, PERK,
Ire-1a and GRP78) were analyzed by western blot. As shown
in Figure 5A, 6 h OGD induced a significant reduction in
chaperone proteins calnexin, PERK, GRP78 and Ire-1a, and
this reduction was significantly inhibited by knockdown of
ENOPH1 with siRNA. ROS generation was assessed by DCFH
staining and flow cytometry. As shown in Figures 5B,C, 6 h
OGD induced a significant increase in DCFH fluorescence
(green) intensity in bEND3 cells, indicative of increased ROS
generation, which was inhibited by ENOPH1 siRNA, but not
by control siRNA. Similar results were obtained when using
flow cytometry to quantitate ROS generation in OGD-induced
bEND3 cells transfected with ENOPH1 siRNA or control
siRNA (Figure 5D). These results suggest that ENOPH1 may
retard ER stress protective effect and potentiate ROS generation
to promote endothelial cell death/apoptosis under OGD
conditions.
ENOPH1 Overexpression Enhances
OGD-Induced Endothelial Injury and
Oxidative Stress
To further verify an important role of ENOPH1 in potentiating
endothelial cell death/apoptosis under OGD conditions,
we transfected bEND3 cells with ENOPH1 CRISPR
activation plasmid to elevate the ENOPH1 expression
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FIGURE 4 | Knockdown of ENOPH1 attenuates OGD-induced apoptosis-related protein expression in bEND3 cells. bEND3 cells transfected with
siENOPH1 (siENO) or control siRNA (siCon) before exposing to OGD for 6 h. Apoptosis-related proteins were analyzed by western blot. (A) Upper panel:
representative immunoblots showing the changes of cleaved and full length caspase-3 and PARP protein bands in bEND3 cells. β-actin was used as a loading
control; bottom panel: quantitative data showed that OGD significantly increased the cleavage of caspase-3 and PARP and knockdown of ENOPH1 inhibited this
change. ∗P < 0.05 vs. siCon; #P < 0.05 vs. siCon + OGD; n = 4. (B) Upper panel: representative immunoblots of Bax and Bcl-2 proteins; bottom panel: quantitative
data showed that OGD significantly increased the ratio of Bax/Bcl-2 and knockdown of ENOPH1 inhibited this increase. ∗P < 0.05 vs. siCon; #P < 0.05 vs.
siCon + OGD; n = 4.
before exposing the cells to OGD treatment for 6 h and
assessed its impact on cell death/apoptosis associated
proteins. As shown in Figure 6A, western blot analysis
showed that bEND3 cells transfected with ENOPH1 plasmid
led to increase in ENOPH1 protein level at 48 h after
transfection compared to control plasmid. Of note, ENOPH1
plasmid had no effect on cell death assessed by measuring
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
formation under control condition, but it significantly
potentiated OGD-induced increase in cell death (Figure 6B).
It also significantly enhanced OGD-induced activation of
apoptosis-associated signal molecules, reflected by greater ratios
of cleaved caspase-3/caspase-3 and Bax/Bcl-2 for OGD plus
ENOPH1 plasmid-treated cells than OGD alone treated cells
(Figures 6C,D). These data indicate that overexpression of
ENOPH1 potentiates endothelial cell death/apoptosis under
OGD conditions.
ENOPH1 Regulates ADI1 Redistribution in
Endothelial Cells Under OGD Condition
ADI1 is a downstream protein of ENOPH1 and has been shown
to play an important role in cell apoptosis, oxidoreductase
reaction and virus infection (Hirano et al., 2005; Oram et al.,
2007; Cheng et al., 2009). Therefore, we speculated that
ADI1 might mediate the effect of ENOPH1 on OGD-induced
endothelial cell death. To investigate this possibility, we
studied the interaction between these two proteins. First, we
examined the changes of ADI1 expression in OGD-treated
bEND3 cells. As shown in Figure 7A, ADI1 mRNA expression
was increased at 1 h after OGD treatment, which, unlike
ENOPH1, was not further increased when OGD duration
was prolonged to 3 h or 6 h. The change of ADI1 protein
seemed to lag behind its mRNA, as bEND3 cells did not show
increased ADI1 protein levels at 1 h OGD treatment and the
increase in ADI1 protein was only seen after 3 or 6 h OGD
(Figure 7B). To our surprise, knockdown of ENOPH1 with
siRNA did not affect ADI1 protein expression under both
normoxic and OGD conditions (Figure 7C), indicating that
OGD-induced ADI1 upregulation was not ENOPH1-dependent.
Interestingly, ENOPH1 knockdown significantly stimulated
the translocation of ADI1 from the nuclei to the cytosol
(Figure 7D). To demonstrate a direct interaction of ENOPH1
with ADI1, we conducted coimmunoprecipitation experiments.
As shown in Figure 7E, ADI1 coimmunoprecipitated with
ENOPH1 and OGD treatment enhanced the interaction of
ENOPH1 with ADI1 by approximately one-fold over the
control group (Figure 7E). Collectively, these data demonstrate
that ENOPH1 might interact with ADI1 to restrict ADI1 in
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FIGURE 5 | Knockdown of ENOPH1 inhibits OGD-induced oxidative stress in bEND3 cells. Down-regulation of ENOPH1 on OGD induced Endoplasmic
reticulum (ER) stress signaling were determined by western blot. (A) Upper panel: representative immunoblots showing the changes of Ire-1a, calnexin, GRP78 and
PERK protein bands in bEND3 cells after 6 h OGD treatment, with or without siENOPH1 transfection; bottom panel: quantitative data showed that OGD significantly
decreased the mentioned ER stress chaperon protein level and knockdown of ENOPH1 inhibited this change. β-actin was used as a loading control. ∗P < 0.05 vs.
siCon; #P < 0.05 vs. siCon + OGD; n = 4. (B) bEND3 cells transfected with siENOPH1 or control were loaded with DCF-DA (10 µM) to detect intracellular reactive
oxygen species (ROS) production. Representative microscope pictures were shown (bar = 100 µm). (C) Quantification data showed that OGD significantly increased
ROS production and knockdown of ENOPH1 inhibited ROS increase. ∗P < 0.05 vs. control; #P < 0.05 vs. OGD; n = 4. (D) Representative flow cytometry of cells
transfected with or without siENOPH1 after 6 h OGD treatment. Cells were stained with DCF-DA solution and then the levels of intracellular ROS were analyzed by
flow cytometry; n = 4.
the nucleus and this interaction was enhanced under OGD
conditions.
Knockdown of ENOPH1 Reduces
OGD-Induced Increase in the Permeability
of bEND3 Cell Monolayer
The above data have demonstrated a role of ENOPH1 in
contributing to brain endothelial cell death under ischemic
conditions, therefore we speculated that ENOPH1 was involved
in OGD-induced endothelial barrier disruption. To test this
possibility, we assessed the impact of ENOPH1 siRNA on the
permeability of endothelial cell monolayer to FITC-dextran
under control or OGD conditions. bEND3 cells were pre-treated
with ENOPH1 siRNA before exposing to OGD for 6 h. As
expected, 6 h OGD significantly increased the permeability of
bEND3 cell monolayer to FITC-dextran (Figure 8). ENOPH1
siRNA, but not scrambled control siRNA, significantly reduced
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FIGURE 6 | Overexpression of ENOPH1 aggravates OGD-induced apoptosis in bEND3 cells. (A) The ENOPH1 CRISPR activated plasmid effectively
increased ENOPH1 protein expression in bEND3 cells. Upper panel: representative immunoblots showing the changes of ENOPH1 protein bands in bEND3 cells
after 6 h OGD treatment, with or without ENOPH1 CRISPR activated plasmid (ENO-Vec) transfection; bottom panel: quantitative data showed that transfecting cells
with ENO-Vec for 48 h significantly enhanced ENOPH1 protein levels ∗P < 0.05 vs. control activated plasmid (Con-Vec); n = 4. (B) ENOPH1 overexpression
significantly increased 6 h OGD induced cell death assessed by lactate dehydrogenase release. ∗P < 0.05 vs. Con-Vec; #P < 0.05 vs. Con-Vec + OGD; n = 4.
(C) Upper panel: representative immunoblots showing the changes of cleaved and full length caspase-3 protein bands in bEND3 cells. β-actin was used as a loading
control; bottom panel: quantitative data showed that OGD significantly increased the cleavage of caspase-3 and PARP and overexpression of ENOPH1 aggregated
this change. ∗P < 0.05 vs. Con-Vec; #P < 0.05 vs. Con-Vec + OGD; n = 4. (D) Upper panel: representative immunoblots of Bax and Bcl-2 proteins; bottom panel:
quantitative data showed that OGD significantly increased the ratio of Bax/Bcl-2 and overexpression of ENOPH1 promoted this increase. ∗P < 0.05 vs. Con-Vec;
#P < 0.05 vs. Con-Vec + OGD; n = 4.
the permeability of OGD-treated endothelial monolayer to FITC-
dextran (Figure 8). These results indicate that ENOPH1 is
involved in OGD-induced loss of endothelial barrier function
under ischemic conditions.
DISCUSSION
ENOPH1 is a newly identified enzyme of the methionine
salvage pathway, and has been found to play a role in stress
reactivity (Barth et al., 2014). In this study, we demonstrated
a new role of ENOPH1 in mediating BBB injury under
OGD conditions, which is a model of cerebral ischemia. The
major findings include: (1) MCAO and OGD significantly
increase ENOPH1 expression in cerebral microvessels and
cultured brain endothelial cells (bEND3 cells), respectively;
(2) knockdown of ENOPH1 with siRNA significantly attenuates
OGD-induced bEND3 cell death and the activation of apoptosis-
associated signal molecules, and accordingly overexpression
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FIGURE 7 | ENOPH1 mediates OGD-induced ADI-1 relocation in endothelial cells. (A) Real time RT-PCR analysis showed that aci-reductone dioxygenase 1
(ADI1) mRNA expression was significantly increased in bEND3 cells at 1 h after OGD treatment and was further increased when OGD was prolonged to 6 h.
∗P < 0.05 vs. Con; n = 4. (B) Western blot analysis showed that ADI1 protein levels were increased in 3 h OGD and 6 h OGD treated cells. Upper panel:
representative immunoblots of ADI1 and the loading control β-actin; bottom panel: quantitative data of protein band intensity after normalization to β-actin.,
∗P < 0.05 vs. Con; n = 4. (C) Upper panel: representative immunoblots of ADI1 and the loading control β-actin; bottom panel: quantitative data showed that
transfected with ENOPH1 siRNA had not prevented OGD induced upregulation of total protein level of ADI in bEND3 cells. ∗P < 0.05 vs. siCon; n = 4. (D) Upper
panel: representative immunoblots of ADI1 and the loading control β-actin; bottom panel: quantitative data showed that following OGD treatment, ADI1 levels in the
CF was increased, while its level in CN was markedly reduced, which was enhanced by ENOPH1 siRNA. ∗P < 0.05 vs. siCon, #P < 0.05 vs. siCon + OGD; CF,
cytosolic fraction; CN, cytosolic nuclei; n = 4. (E) Left panel: representative immunoblots of coimmunoprecipitation of ENOPH1 and ADI1 from whole cell lysates of
control cultures or OGD-treated cells with anti-ENOPH1 antibody or normal anti-IgG; right panel: quantitative data showed that OGD enhanced interaction of
ENOPH1 with ADI1. ∗P < 0.05 vs. Con; n = 4.
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FIGURE 8 | Knockdown of ENOPH1 with siRNA reduces OGD induced
blood brain barrier (BBB) disruption in vitro. The permeability of
fluorescein isothiocyanate (FITC)-dextran across bEND3 monolayers was
significantly increased after 6 h OGD. This was partially inhibited by pretreating
cells with ENOPH1 siRNA. The permeability of the endothelial monolayer was
assessed by calculating the transfer rate of FITC-dextran from the luminal
compartment to the abluminal compartment, and was expressed as the
apparent permeability coefficient (Papp, cm/s). ∗P < 0.05 vs. Con, #P < 0.05
vs. siCon + OGD; n = 4. Papp [cm/s] = dQ/(dt∗A∗Co), dQ: the amount of
FITC-dextran getting into the abluminal compartment; dt : duration of OGD
treatment; dQ/dt : the rate of transfer (ng/s); A: surface area (cm2); Co: the
initial concentration in the luminal chamber (ng/cm3).
of ENOPH1 with CRISPR-activated plasmid potentiates these
changes; (3) knockdown of ENOPH1 attenuates OGD-induced
ROS generation and ER stress; (4) OGD potentiates the
interaction between ENOPH1 and its downstream molecule
ADI1, increases ADI1 expression and promotes ADI1’s
translocation into the cytosol; (5) ENOPH1 appears to restrain
ADI1’s translocation from the nucleus to the cytosol, but does
not affect OGD-induced ADI1 upregulation; and (6) knockdown
of ENOPH1 attenuates OGD-induced endothelial barrier
disruption.
Currently, the biological functions of ENOPH1 are largely
unknown. A few recent studies have shown that ENOPH1
is widely expressed in the brain and is associated with
neurodevelopmental disorders and anxiety (Barth et al., 2014;
Komlósi et al., 2015). As the first study, here we investigated the
role of ENOPH1 in ischemic stroke with a focus on the BBB.
Our data show that both in vivo and in vitro ischemia induce
ENOPH1 upregulation in cerebral microvascular endothelial
cells. Of note, this change is quite rapid and persistent, as
ENOPH1 mRNA expression was found to be increased in
endothelial cells at 1 h after OGD treatment and remained
high at the end of 6 h OGD exposure. Under our experimental
conditions, significant cytotoxicity was only observed for 6 h
OGD, but not for 1 h OGD and 3 h OGD, which was consistent
with our previous studies (Liu et al., 2012, 2015). Therefore,
in this study, 6 h OGD was chosen to test whether ENOPH1
contributes to brain endothelial cell death under ischemic
conditions.
Our data show that knockdown of ENOPH1 with siRNA
reduces OGD-induced cell death/apoptosis, while overexpressing
ENOPH1 by transfecting ENOPH1 CRISPR activation plasmid
results in a higher cell death rate in brain endothelial cells, which
clearly supports a role of ENOPH1 in OGD-induced endothelial
cell death/apoptosis. Moreover, along with ENOPH1 knockdown
or overexpression is the inhibition or activation of apoptosis-
associated proteins, including cleaved caspase-3, cleaved PARP,
Bax and Bcl-2, further supporting a proapoptotic action of
ENOPH1.
Increased free radical generation and impaired function of
the (ER stress) are two common pathophysiological events
occurring in the ischemic brain (Olmez and Ozyurt, 2012; Yu
et al., 2016). Here, our data have also shown increased ROS
generation in brain endothelial cells after 6 h OGD treatment.
Of note, knockdown of ENOPH1 with siRNA markedly
attenuated OGD-induced ROS generation in endothelial cells,
suggesting that ENOPH1may contribute to ischemic endothelial
cell death via promoting intracellular ROS generation. Under
ischemic conditions, there are several enzymatic and non-
enzymatic sources of ROS generation, such as NADPH
oxidase (Hur et al., 2010), the mitochondrial respiratory
chain (Sanderson et al., 2013), and xanthine oxidase (Ono
et al., 2009). In this study, we did not further explore the
mechanism by which ENOPH1 enhances ROS generation
under OGD condition. To our surprise, ischemic brain
endothelial cells appear to have suppressed ER stress under
our experimental conditions, as 6 h OGD led to suppressed
expression of ER-stress associated proteins (Ire-1a, Calnexin,
GRP78, and PERK). Moreover, ENOPH1 appears to act as
an ER stress suppressor because knockdown of ENOPH1
significantly reverses OGD-induced suppression of ER stress-
associated proteins. Our possible explanation for this unexpected
observation would be ENOPH1 protein levels could retard
ER stress protective effect by inhibiting some ER molecular
chaperones (such as GRP78) expression in endothelial cells under
OGD conditions.
ADI1 is a downstream molecule of ENOPH1 in methionine
salvage pathway and has been shown to be implicated in
cell apoptosis, cell growth inhibition, oxidoreductase reaction
and virus infection (Hirano et al., 2005; Oram et al., 2007;
Cheng et al., 2009). In addition, ADI1 is an oxidoreductase
and can combine molecular oxygen donor to generate ROS
(Oram et al., 2007). This known evidence has promoted us
to hypothesize that ADI1 may mediate ENOPH1’s effect on
promoting ischemic endothelial cell death. Our data show that
OGD induces ADI1 mRNA and protein upregulation in a
time-dependent manner similar to ENOPH1. To our surprise,
although the coimmunoprecipitation assay clearly shows that
ADI1 interacts with ENOPH1, knockdown of ENOPH1 does
not affect OGD-induced ADI1 upregulation. Another interesting
finding is that OGD increases the translocation of ADI1 from
the nucleus to the cytosol and knockdown of ENOPH1 enhances
this translocation. Our data raise several important questions: (i)
what promotes the translocation of ADI1 to the cytosol under
ischemic conditions; (ii) what translocated ADI1 does in the
cytosol; and (iii) how ENOPH1 potentiates ADI1 translocation
to the cytosol. Future studies are warranted to answer these
questions.
Last, our data that knockdown of ENOPH1 partially
inhibits OGD-induced permeability increase of the endothelial
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monolayer support an important role of ENOPH1 in ischemic
BBB injury. It is well known that the brain capillary endothelial
cells and the tight junctions between adjacent endothelial cells are
the two most important structural components that maintain the
integrity of the BBB (ElAli et al., 2011; Jumnongprakhon et al.,
2016). Our current study was only focused the effect of ENOPH1
on ischemic endothelial injury and did not study its impact on
the tight junctions. As a fact, ENOPH1’s downstream molecule
ADI1 can bind to and inhibit the activity of membrane-type
matrix metalloproteinase (MT1-MMP; Uekita et al., 2004; Chang
et al., 2016), and our data demonstrate that ENOPH1 enhances
the translocation of ADI1 to the nucleus under OGD conditions.
As thus, there is a great possibility that ENOPH1 may act as a
separator to pushADI1 away from theMT1-MMP (located in cell
membrane and the cytosol), and thus activate MT1-MMP. The
latter in turn activatesMMP-2 tomediate the degradation of tight
junction proteins and the components of the basal membrane,
leading to BBB disruption (Yang et al., 2007). Future studies are
needed to test this possibility.
Taken together, our present study defines a novel role
of ENOPH1 in ischemic brain injury, in which cerebral
ischemia triggers ENOPH1 upregulation in brain endothelial
cells, leading to increased ROS generation and the activation
of apoptosis associated molecules to contribute to ischemic cell
death. Moreover, under OGD condition, ENOPH1 promotes
the translocation of its downstream molecule ADI1 from the
cytoplasm to the nucleus, future studies are needed to investigate
the mechanisms underlying this change and its biological
consequence.
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